RUA Life Sciences【RUA】銘柄情報

RUA Life Sciences Plc (RUA) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

23.00

( 4.55% )

買値

22.00

売値

24.00

出来高

194,500

平均取引量 (3 か月)

269,257p

財務取引量

22.00 日の範囲 23.00

10.50 52 週間の範囲 26.50

時価総額

14.274M

企業価値

10.618M

前日終値

22.00

始値

22.00

時刻

100000

22.9175

(O)

最終取引時間

VWAP

歳入

4.46M

純利益

-145.33k

発行済株式数

62,060,272

浮動株比率 (%)

81.73%

機関投資家保有比率 (%)

61.99%

配当利回り

PER

-89.71

株価売上高倍率 (PSR)

2.92

1 株当たり利益 (EPS)

-0

ベータ

0.95

RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intell... RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast-Eon and ECSil; and provides sub-contract manufacturing, assembly, packing, and services of medical device, as well as implantable fabric. It also engages in the development and commercialization of bore polymer sealed grafts and soft tissue patches; and development of tri-leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom. 詳細を表示

セクター

Health Care

業界

Health Care Equipment & Supplies

ウェブサイト

rualifesciences.com

本社

Irvine, United Kingdom

設立

1996

RUA Life Sciences Plc is listed in the Health Care sector of the ロンドン証券取引所 with ticker RUA. The last closing price for RUA Life Sciences was 22p. Over the last year, RUA Life Sciences shares have traded in a share price range of 10.50p to 26.50p.

RUA Life Sciences currently has 62,060,272 shares in issue. The market capitalisation of RUA Life Sciences is £14.27 million. RUA Life Sciences has a price to earnings ratio (PE ratio) of -89.71.

Cavendish - Morning Note – 30 June 2026

RUA Life Sciences delivers improved profitability as manufacturing business strengthens and spin-out strategy advances (RUA)

RUA Life Sciences (LSE:RUA) reported interim results for the six months ended 31 March 2026 showing significantly improved financial performance...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	4	21.0526315789	19	23	19	142960	20.86097339	DE
4	4	21.0526315789	19	23	16.9	83975	19.73080121	DE
12	5	27.7777777778	18	26.5	16.9	238156	20.96840711	DE
26	9	64.2857142857	14	26.5	12.25	211996	17.84526407	DE
52	11.25	95.7446808511	11.75	26.5	10.5	174944	15.55452575	DE
156	-8	-25.8064516129	31	58.5	8.65	285732	13.44503338	DE
260	-106.5	-82.2393822394	129.5	167.5	8.65	187214	18.38278229	DE